AA Pharma Currently Offers:

  • A broad range of products across different therapeutic areas.
  • An enhanced presence in CNS with brands such as ELAVIL® (amitriptyline), AVENTYL® (nortriptyline), and LITHMAX® (lithium carbonate).
Elavil®, Aventyl®, and Lithmax® are registered trademarks owned by the respective owners and used with permission.

Click here for a closer look at our diversified portfolio.

Commitment to Access and Patient Care

AA-clozapine is now available to Canadian patients. It is currently the only Canadian-made treatment indicated for the symptoms of treatment-resistant schizophrenia.

AA Pharma is committed to providing continuing access to this well-established product and to a comprehensive patient care network.

For Healthcare Professionals prescribing AA‑Mefloquine, please note that the Product Monograph has been updated to include the patient “checklist for the Prescription of Mefloquine Chemoprophylaxis”.

Click the hyperlinks below to Download the Checklist and/or the Product Monograph for your review.

Product Monograph
Checklist for Mefloquine Chemoprophylaxis